Publication | Open Access
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
1.4K
Citations
34
References
2020
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1